Top

Published in:

01-07-2021 | Prostatectomy | Topic Paper

Reasons to overthrow TURP: bring on Aquablation

Authors: Iman Sadri, Adel Arezki, Félix Couture, David-Dan Nguyen, Russell Schwartz, Ahmed S. Zakaria, Dean Elterman, Enrique Rijo, Vincent Misrai, Thorsten Bach, Claus G. Roehrborn, Kevin C. Zorn

Published in: World Journal of Urology | Issue 7/2021

Abstract

Purpose

In this review, we will discuss the state of the literature regarding Aquablation, its limitations, and opportunities for its application in the treatment of benign prostatic enlargement (BPE).

Methods

A comprehensive review of original research on Aquablation was conducted. Articles related to transurethral resection of the prostate, holmium laser enucleation of the prostate, greenlight photoselective vaporization of the prostate, and simple prostatectomy were reviewed for discussion.

Results

For small–medium prostates (30–80 mL), Aquablation’s main advantages include better ejaculatory function and similar functional outcomes compared to TURP. For large prostates (80–150 mL), Aquablation demonstrates shorter operative time and superior ejaculatory function when compared to simple prostatectomy, HoLEP, and Greenlight PVP. In addition, Aquablation displays shorter hospital stays than simple prostatectomy. The integration of software programming and semi-automatic technology increases the reproducibility of the procedure and helps standardize overall outcomes, while also accelerating the learning curve. Its ability to preserve antegrade ejaculation makes Aquablation a very compelling option for sexually active patients. However cost and postoperative bleeding risks remain a concern.

Conclusion

The current evidence suggests that Aquablation is a safe and effective alternative for BPE for small to large prostates. Further prospective clinical trials, with comparisons to other BPE modalities, and data from longer follow-up periods are still required.

Lokeshwar SD, Harper BT, Webb E et al (2019) Epidemiology and treatment modalities for the management of benign prostatic hyperplasia. Transl Androl Urol 8:529–539. https://doi.org/10.21037/tau.2019.10.01CrossRefPubMedPubMedCentral

Oelke M, Bachmann A, Descazeaud A et al (2013) EAU guidelines on the treatment and follow-up of non-neurogenic male lower urinary tract symptoms including benign prostatic obstruction. Eur Urol 64:118–140. https://doi.org/10.1016/j.eururo.2013.03.004CrossRefPubMed

Foster HE, Dahm P, Kohler TS et al (2019) Surgical Management of lower urinary tract symptoms attributed to benign prostatic hyperplasia: AUA guideline amendment 2019. J Urol 202:592–598. https://doi.org/10.1097/JU.0000000000000319CrossRefPubMed

Rassweiler J, Teber D, Kuntz R, Hofmann R (2006) Complications of transurethral resection of the prostate (TURP)-incidence, management, and prevention. Eur Urol 50:969–979. https://doi.org/10.1016/j.eururo.2005.12.042CrossRefPubMed

Pariser JJ, Packiam VT, Adamsky MA, Bales GT (2016) Trends in simple prostatectomy for benign prostatic hyperplasia. Curr Urol Rep 17:57. https://doi.org/10.1007/s11934-016-0610-6CrossRefPubMed

Desai M, Bidair M, Bhojani N et al (2019) WATER II (80–150 mL) procedural outcomes. BJU Int 123:106–112. https://doi.org/10.1111/bju.14360CrossRefPubMed

Faber K, De Abreu ALC, Ramos P et al (2015) Image-guided robot-assisted prostate ablation using water jet-hydrodissection: initial study of a novel technology for benign prostatic hyperplasia. J Endourol 29:63–69. https://doi.org/10.1089/end.2014.0304CrossRefPubMed

Misrai V, Rijo E, Zorn KC et al (2019) Waterjet ablation therapy for treating benign prostatic obstruction in patients with small- to medium-size glands: 12-month results of the first french aquablation clinical registry. Eur Urol 76:667–675. https://doi.org/10.1016/j.eururo.2019.06.024CrossRefPubMed

Desai MM, Singh A, Abhishek S et al (2018) Aquablation therapy for symptomatic benign prostatic hyperplasia: a single-centre experience in 47 patients. BJU Int 121:945–951. https://doi.org/10.1111/bju.14126CrossRefPubMed

10.

Gilling P, Reuther R, Kahokehr A, Fraundorfer M (2016) Aquablation—Image-guided robot-assisted waterjet ablation of the prostate: Initial clinical experience. BJU Int 116:923–929. https://doi.org/10.1111/bju.13358CrossRef

11.

Gilling P, Barber N, Bidair M et al (2018) WATER: A Double-blind, randomized, controlled trial of aquablation® vs transurethral resection of the prostate in benign prostatic hyperplasia. J Urol 199:1252–1261. https://doi.org/10.1016/j.juro.2017.12.065CrossRefPubMed

12.

Gravas S., Cornu J.N., Gacci M., Gratzke C., Herrmann T.R.W., Mamoulakis C., Rieken M., Speakman M.J. TKAO (2020) EAU guidelines on management of non-neurogenic male lower urinary tract symptoms (LUTS), incl. Benign Prostatic Obstruction (BPO). https://uroweb.org/guideline/treatment-of-non-neurogenic-male-luts/. Accessed 25 Mar 2020

13.

Bahls T, Fröhlich FA, Hellings A et al (2017) Extending the capability of using a waterjet in surgical interventions by the use of robotics. IEEE Trans Biomed Eng 64:284–294. https://doi.org/10.1109/TBME.2016.2553720CrossRefPubMed

14.

Bach T, Giannakis I, Bachmann A et al (2019) Aquablation of the prostate: single-center results of a non-selected, consecutive patient cohort. World J Urol 37:1369–1375. https://doi.org/10.1007/s00345-018-2509-yCrossRefPubMed

15.

Zorn KC, Larry Goldenberg S, Paterson R et al (2019) Aquablation among novice users in Canada: a WATER II subpopulation analysis. Can Urol Assoc J 13:E113–E118. https://doi.org/10.5489/cuaj.5501CrossRefPubMed

16.

Brunckhorst O, Ahmed K, Nehikhare O et al (2015) Evaluation of the learning curve for holmium laser enucleation of the prostate using multiple outcome measures. Urology 86:824–829. https://doi.org/10.1016/j.urology.2015.07.021CrossRefPubMed

17.

Kampantais S, Dimopoulos P, Tasleem A et al (2018) Assessing the learning curve of holmium laser enucleation of prostate (HoLEP). Syst Rev Urol 120:9–22. https://doi.org/10.1016/j.urology.2018.06.012CrossRef

18.

Bastard C, Zorn K, Peyronnet B, Hueber PA, Pradère B, Rouprêt M, M V. (2019) Assessment of learning curves for 180-W GreenLight XPS photoselective vaporisation of the prostate: a multicentre study. Eur Urol Focus 5:266–272. https://doi.org/10.1016/j.euf.2017.09.011CrossRefPubMed

19.

Furuya S, Furuya R, Ogura H et al (2006) A study of 4,031 patients of transurethral resection of the prostate performed by one surgeon: learning curve, surgical results and postoperative complications. Acta Urol Jpn 52:609–614

20.

Nguyen DD, Bhojani N, Zorn KC (2019) Furthering the external validity of Aquablation and implications for real-world patients. World J Urol 37:1983–1984. https://doi.org/10.1007/s00345-018-2610-2CrossRefPubMed

21.

Kasivisvanathan V, Hussain M (2018) Aquablation versus transurethral resection of the prostate: 1 year United States—cohort outcomes. Can J Urol 25:9317–9322PubMed

22.

Bach T, Gilling P, El Hajj A et al (2020) First multi-center all-comers study for the Aquablation procedure. J Clin Med 9:603. https://doi.org/10.3390/jcm9020603CrossRefPubMedCentral

23.

Nguyen D-D, Misraï V, Bach T et al (2020) Operative time comparison of Aquablation, greenlight PVP, ThuLEP, GreenLEP, and HoLEP. World J Urol. https://doi.org/10.1007/s00345-020-03137-8CrossRefPubMed

24.

Bhojani N, Nguyen D-D, Kaufman RPJ et al (2019) Comparison of < 100 cc prostates and > 100 cc prostates undergoing Aquablation for benign prostatic hyperplasia. World J Urol 37:1361–1368. https://doi.org/10.1007/s00345-018-2535-9CrossRefPubMed

25.

Uchida T, Ohori M, Soh S et al (1999) Factors influencing morbidity in patients undergoing transurethral resection of the prostate. Urology 53:98–105. https://doi.org/10.1016/S0090-4295(98)00524-XCrossRefPubMed

26.

Nguyen DD, Barber N, Bidair M et al (2020) Waterjet ablation therapy for endoscopic resection of prostate tissue trial (WATER) vs WATER II: comparing Aquablation therapy for benign prostatic hyperplasia in 30–80 and 80–150 mL prostates. BJU Int 125:112–122. https://doi.org/10.1111/bju.14917CrossRefPubMed

27.

Gilling P, Barber N, Bidair M et al (2020) Three-year outcomes after Aquablation therapy compared to TURP: results from a blinded randomized trial. Can J Urol 27:10072–10079PubMed

28.

Yalçın S, Yılmaz S, Gazel E et al (2020) Holmium laser enucleation of the prostate for the treatment of size-independent BPH: a single-center experience of 600 cases. Turkish J Urol 46:219–225. https://doi.org/10.5152/tud.2020.19235CrossRef

29.

Valdivieso R, Hueber PA, Meskawi M et al (2018) Multicentre international experience of 532-nm laser photoselective vaporization with GreenLight XPS in men with very large prostates. BJU Int 122:873–878. https://doi.org/10.1111/bju.14208CrossRefPubMed

30.

Gilling P, Barber N, Bidair M et al (2019) Two-year outcomes after Aquablation compared to TURP: efficacy and ejaculatory improvements sustained. Adv Ther 36:1326–1336. https://doi.org/10.1007/s12325-019-00952-3CrossRefPubMedPubMedCentral

31.

Gilling P, Anderson P, Tan A (2017) Aquablation of the prostate for symptomatic benign prostatic hyperplasia: 1-year results. J Urol 197:1565–1572. https://doi.org/10.1016/j.juro.2017.01.056CrossRefPubMed

32.

Desai M, Bidair M, Bhojani N et al (2020) Aquablation for benign prostatic hyperplasia in large prostates (80–150 cc): 2-year results. Can J Urol 27:10147–10153PubMed

33.

Bhojani N, Bidair M, Zorn KC et al (2019) Aquablation for benign prostatic hyperplasia in large prostates (80–150 cc): 1-Year Results. Urology 129:1–7. https://doi.org/10.1016/j.urology.2019.04.029CrossRefPubMed

34.

Krambeck AE, Handa SE, Lingeman JE (2010) Experience with more than 1000 holmium laser prostate enucleations for benign prostatic hyperplasia. J Urol 198:663–670. https://doi.org/10.1016/j.juro.2009.11.034CrossRef

35.

Rosen RC (2006) Assessment of sexual dysfunction in patients with benign prostatic hyperplasia. BJU Int 97:29–33. https://doi.org/10.1111/j.1464-410X.2006.06103.xCrossRefPubMed

36.

Reale G, Cimino S, Bruno G et al (2019) “Aquabeam® system” for benign prostatic hyperplasia and LUTS: birth of a new era. A systematic review of functional and sexual outcome and adverse events of the technique. Int J Impot Res 31:392–399. https://doi.org/10.1038/s41443-019-0158-3CrossRefPubMed

37.

Suarez-Ibarrola R, Bach T, Hein S et al (2019) Efficacy and safety of Aquablation of the prostate for patients with symptomatic benign prostatic enlargement: a systematic review. World J Urol 38:1147–1163. https://doi.org/10.1007/s00345-019-02959-5CrossRefPubMed

38.

Rosen RC, Riley A, Wagner G et al (1997) The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology 49:822–830. https://doi.org/10.1016/S0090-4295(97)00238-0CrossRefPubMed

39.

Rosen RC, Catania J, Pollack L et al (2004) Male sexual health questionnaire (MSHQ): scale development and psychometric validation. Urology 64:777–782. https://doi.org/10.1016/j.urology.2004.04.056CrossRefPubMed

40.

Sturch P, Woo HH, McNicholas T, Muir G (2015) Ejaculatory dysfunction after treatment for lower urinary tract symptoms: retrograde ejaculation or retrograde thinking? BJU Int 115:186–187. https://doi.org/10.1111/bju.12868CrossRefPubMed

41.

Bachmann A, Tubaro A, Barber N et al (2014) 180-W XPS greenlight laser vaporisation versus transurethral resection of the prostate for the treatment of benign prostatic obstruction: 6-month safety and efficacy results of a European multicentre randomised trial - The GOLIATH study. Eur Urol 65:931–942. https://doi.org/10.1016/j.eururo.2013.10.040CrossRefPubMed

42.

Marra G, Sturch P, Oderda M et al (2016) Systematic review of lower urinary tract symptoms/benign prostatic hyperplasia surgical treatments on men’s ejaculatory function: time for a bespoke approach? Int J Urol 23:22–35. https://doi.org/10.1111/iju.12866CrossRefPubMed

43.

Elterman D, Bach T, Rijo E et al (2020) Transfusion rates after 800 Aquablation procedures using various haemostasis methods. BJU Int 125:568–572. https://doi.org/10.1111/bju.14990CrossRefPubMedPubMedCentral

44.

Pariser JJ, Pearce SM, Patel SG, Bales GT (2015) National trends of simple prostatectomy for benign prostatic hyperplasia with an analysis of risk factors for adverse perioperative outcomes. Urology 86:721–725. https://doi.org/10.1016/j.urology.2015.06.048CrossRefPubMed

45.

Gratzke C, Schlenker B, Seitz M et al (2007) Complications and early postoperative outcome after open prostatectomy in patients with benign prostatic enlargement: results of a prospective multicenter study. J Urol 177:1419–1422. https://doi.org/10.1016/j.juro.2006.11.062CrossRefPubMed

46.

Zheng X, Peng L, Cao D et al (2019) Holmium laser enucleation of the prostate in benign prostate hyperplasia patients with or without oral antithrombotic drugs: a meta-analysis. Int Urol Nephrol 51:2127–2136. https://doi.org/10.1007/s11255-019-02278-zCrossRefPubMed

47.

Misraï V, Pasquie M, Bordier B et al (2018) Comparison between open simple prostatectomy and green laser enucleation of the prostate for treating large benign prostatic hyperplasia: a single-centre experience. World J Urol 36:793–799. https://doi.org/10.1007/s00345-018-2192-zCrossRefPubMed

48.

Mebust WK, Holtgrewe HL, Cockett ATK et al (2002) Transurethral prostatectomy: immediate and postoperative complications. Cooperative study of 13 participating institutions evaluating 3,885 patients. J Urol 167:5–9. https://doi.org/10.1016/S0022-5347(05)65370-0CrossRefPubMed

49.

Lerner LB, Tyson MD, Mendoza PJ (2010) Stress incontinence during the learning curve of holmium laser enucleation of the prostate. J Endourol 24:1655–1658. https://doi.org/10.1089/end.2010.0021CrossRefPubMed

50.

Tubaro A, Carter S, Hind A et al (2001) A prospective study of the safety and efficacy of suprapubic transvesical prostatectomy in patients with benign prostatic hyperplasia. J Urol 166:172–176. https://doi.org/10.1016/S0022-5347(05)66102-2CrossRefPubMed

51.

Serretta V, Morgia G, Fondacaro L et al (1990s) Open prostatectomy for benign prostatic enlargement in southern Europe in the late 1990s: a contemporary series of 1800 interventions. Urology 60:623–627. https://doi.org/10.1016/S0090-4295(02)01860-5CrossRefPubMed

52.

Vavassori I, Valenti S, Naspro R et al (2008) Three-year outcome following holmium laser enucleation of the prostate combined with mechanical morcellation in 330 consecutive patients. Eur Urol 53:599–604. https://doi.org/10.1016/j.eururo.2007.10.059CrossRefPubMed

53.

Elmansy HM, Kotb A, Elhilali MM (2011) Is there a way to predict stress urinary incontinence after holmium laser enucleation of the prostate? J Urol 186:1977–1981. https://doi.org/10.1016/j.juro.2011.06.063CrossRefPubMed

Title: Reasons to overthrow TURP: bring on Aquablation
Authors: Iman Sadri
Adel Arezki
Félix Couture
David-Dan Nguyen
Russell Schwartz
Ahmed S. Zakaria
Dean Elterman
Enrique Rijo
Vincent Misrai
Thorsten Bach
Claus G. Roehrborn
Kevin C. Zorn
Publication date: 01-07-2021
Publisher: Springer Berlin Heidelberg
Keywords: Prostatectomy
Transurethral Prostate Resection
Prostatectomy
Published in: World Journal of Urology / Issue 7/2021
Print ISSN: 0724-4983
Electronic ISSN: 1433-8726
DOI: https://doi.org/10.1007/s00345-020-03390-x

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Reasons to overthrow TURP: bring on Aquablation

Abstract

Purpose

Methods

Results

Conclusion

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 7/2021

Evaluation, diagnosis and surveillance of renal masses in the setting of VHL disease

Comparison of risk-calculator and MRI and consecutive pathways as upfront stratification for prostate biopsy

A prospective multicenter randomized comparison between Holmium Laser Enucleation of the Prostate (HoLEP) and Thulium Laser Enucleation of the Prostate (ThuLEP)

Correction to: Endoscopic enucleation of the prostate (EEP). The same but different—a systematic review

HoLEP for acute and non-neurogenic chronic urinary retention: how effective is it?

The association between anogenital distance and benign prostatic hyperplasia related lower urinary tract symptoms in Chinese aging men